BioCentury | Mar 5, 2015
Distillery Therapeutics

Therapeutics: S. aureus M42 family glutamyl aminopeptidase (PepA1)

...Bacterial infection Cell culture studies suggest a cyclic heptapseudopeptide derived from the Staphylococcus aureus toxin PepA1...
...human sera, the stability of the lead cyclic peptide was about 240-fold greater than the PepA1...
...work includes assessing the toxicity of the peptide in animal models of bacterial infection. TARGET/MARKER/PATHWAY: S. aureus M42 family glutamyl aminopeptidase (PepA1)...
Items per page:
1 - 1 of 1